We are live on ! Find out more
JA

JLB & Associates Portfolio holdings

AUM $696M
1-Year Est. Return 17.86%
This Fund
S&P 500
This Quarter Est. Return
+11.29%
1 Year Est. Return
+17.86%
3 Year Est. Return
+57.72%
5 Year Est. Return
+93.63%
10 Year Est. Return
AUM
$263M
AUM Growth
+$25.4M
Cap. Flow
+$135K
Cap. Flow %
0.05%
Top 10 Hldgs %
30.99%
Holding
75
New
2
Increased
27
Reduced
36
Closed

Sector Composition

Rank Sector Weight
1 Technology 18.7%
2 Consumer Discretionary 17.25%
3 Healthcare 17.05%
4 Industrials 13.85%
5 Consumer Staples 9.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLGN icon
26
Silgan Holdings
SLGN
$4.99B
$4.79M 1.83%
199,704
+10,142
+5% +$236K
CBRL icon
27
Cracker Barrel
CBRL
$1.2B
$4.54M 1.73%
41,255
+1,833
+5% +$199K
CPRT icon
28
Copart
CPRT
$25.6B
$4.22M 1.61%
920,896
+6,000
+0.7% +$25.2K
AMGN icon
29
Amgen
AMGN
$198B
$3.88M 1.48%
34,014
+596
+2% +$67.8K
K
30
DELISTED
Kellanova
K
$3.85M 1.47%
67,196
+13
+0% +$748
OXY icon
31
Occidental Petroleum
OXY
$54.6B
$3.82M 1.46%
41,969
-8,507
-17% -$777K
ALTR
32
DELISTED
Altera Corp
ALTR
$3.71M 1.41%
114,159
-5,131
-4% -$172K
ABBV icon
33
AbbVie
ABBV
$450B
$3.7M 1.41%
70,128
+30
+0% +$1.47K
TPR icon
34
Tapestry
TPR
$28.6B
$3.49M 1.33%
62,253
+361
+0.6% +$19.5K
COL
35
DELISTED
Rockwell Collins
COL
$3.35M 1.28%
45,315
-127
-0.3% -$9.02K
DLTR icon
36
Dollar Tree
DLTR
$24.2B
$3.25M 1.24%
57,637
+285
+0.5% +$16.4K
NVO
37
Novo Nordisk
NVO
$223B
$3.1M 1.18%
167,750
+9,010
+6% +$157K
EXPD icon
38
Expeditors International
EXPD
$23.9B
$3M 1.14%
67,839
-40
-0.1% -$1.75K
XOM icon
39
ExxonMobil
XOM
$611B
$2.87M 1.09%
28,312
-1,491
-5% -$138K
ABT icon
40
Abbott
ABT
$175B
$2.85M 1.09%
74,478
-2,025
-3% -$74.6K
PDCO
41
DELISTED
Patterson Companies, Inc.
PDCO
$2.84M 1.08%
69,014
-240
-0.3% -$9.95K
DHR icon
42
Danaher
DHR
$144B
$2.83M 1.08%
54,467
-1,621
-3% -$79.7K
IBM icon
43
IBM
IBM
$200B
$2.51M 0.96%
13,988
-34
-0.2% -$5.86K
KMB icon
44
Kimberly-Clark
KMB
$36B
$2.38M 0.91%
23,760
CSCO icon
45
Cisco
CSCO
$441B
$2.21M 0.84%
98,694
-1,000
-1% -$22.1K
CNI icon
46
Canadian National Railway
CNI
$78.3B
$2.15M 0.82%
37,741
+3,239
+9% +$178K
LH icon
47
Labcorp
LH
$23.2B
$1.94M 0.74%
24,694
+151
+0.6% +$12.9K
TECH icon
48
Bio-Techne
TECH
$11.2B
$1.89M 0.72%
79,920
LLY icon
49
Eli Lilly
LLY
$1.05T
$1.64M 0.62%
32,109
-500
-2% -$25K
MTD icon
50
Mettler-Toledo International
MTD
$26.5B
$1.6M 0.61%
6,590
-995
-13% -$243K

Similar funds

JLB & Associates's Q4 2013 Portfolio in Review

As of Q4 2013, JLB & Associates held 75 positions worth $263M, up 11% from $237M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Trading was light in Q4 2013: portfolio turnover was 2.7%. JLB & Associates opened 2 new positions and made no exits, leaving the 75-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • JLB & Associates's largest Q4 2013 buy was Global Payments: 13,948 shares worth $453K.
  • JLB & Associates added most to Deluxe in Q4 2013, an estimated $506K increase.
  • JLB & Associates's biggest Q4 2013 reduction was Occidental Petroleum, cutting an estimated $777K.
  • JLB & Associates's ten largest holdings make up 31% of its $263M portfolio in Q4 2013.
  • JLB & Associates opened 2 new positions and closed 0 in Q4 2013.
  • JLB & Associates's portfolio value rose 11% quarter-over-quarter to $263M.

Based on JLB & Associates's 13F filing for Q4 2013, filed 17 Jan 2014.